Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-157.25M
↓ 106% vs avg
Percentile
P0
Near historical low
Streak
4 yr
Consecutive declineContracting
Average
$-76.43M
Historical baseline
PeriodValueYoY Change
TTM$-157.25M-37.6%
2024$-114.25M-118.0%
2023$-52.41M-45.1%
2022$-36.11M-63.0%
2021$-22.16M-